Literature DB >> 15672870

Experimental liver metastasis: standards for local cell implantation to study isolated tumor growth in mice.

Otto Kollmar1, Martin K Schilling, Michael D Menger.   

Abstract

Experimental hepatic metastasis of colorectal tumors is frequently studied by local intrahepatic tumor cell implantation. However, although a variety of factors of the implantation procedure may markedly influence tumor growth characteristics, standards are not defined yet. Herein, we studied the effect of different modes of cell implantation on tumor growth and angiogenesis by in vivo fluorescence microscopy and histology seven days after grafting colorectal CT26.WT tumor cells into the left liver lobe of syngeneic BALB/c mice. We demonstrate that (i) radial growth of cells implanted within the central area of the lobe is inhibited by a regularly observed fissura which crosses at midline the surface of the lobe; (ii) cells suspended during implantation in RPMI show an uncontrolled overwhelming growth 40-fold of those suspended in PBS; (iii) cell implantation in 100 microl and 20 microl suspension medium is significantly more complicated by rupture of the liver capsule, uncontrolled intraparenchymal cell spread and recoil of the cells through the injection canal compared to cells suspended in 10 microl; (iv) the frequency of metastasis within the injection canal and at the puncture site is significantly reduced using 32G compared to 27G or 29G needles; (v) occlusion of the puncture site by acrylic glue or electric coagulation completely abolishes peritoneal tumor spread compared to no treatment or gentle compression by cotton gauze. We conclude that a standardized growth of isolated metastases is best achieved by implanting CT26.WT cells in a 10 microl PBS blister subcapsularly into the paramedian area of the lower surface of the left liver lobe, using a 32-gauge needle and closing the puncture site with acrylic glue.

Entities:  

Mesh:

Year:  2004        PMID: 15672870     DOI: 10.1007/s10585-004-2696-3

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  32 in total

1.  Experimental studies of factors influencing hepatic metastases. I. The effect of number of tumor cells injected and time of growth.

Authors:  E R FISHER; B FISHER
Journal:  Cancer       Date:  1959 Sep-Oct       Impact factor: 6.860

2.  Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Authors:  Peter Vajkoczy; Mohammad Farhadi; Andreas Gaumann; Regina Heidenreich; Ralf Erber; Andreas Wunder; Jörg C Tonn; Michael D Menger; Georg Breier
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Hepatic metastases: rat models for imaging research.

Authors:  M C Chen; Y M Tsang; D D Stark; R Weissleder; S Saini; J Brandhorst; D L White; B L Engelstad; J T Ferrucci
Journal:  Magn Reson Imaging       Date:  1989 Jan-Feb       Impact factor: 2.546

4.  Treatment of liver metastases from colon carcinoma with autologous tumor vaccine expressing granulocyte-macrophage colony-stimulating factor.

Authors:  K W Suh; S Piantadosi; H A Yazdi; D M Pardoll; H Brem; M A Choti
Journal:  J Surg Oncol       Date:  1999-12       Impact factor: 3.454

5.  Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors.

Authors:  J Hanes; A Sills; Z Zhao; K W Suh; B Tyler; F DiMeco; D J Brat; M A Choti; K W Leong; D M Pardoll; H Brem
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

6.  Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.

Authors:  D C Saffran; H M Horton; M A Yankauckas; D Anderson; K M Barnhart; A M Abai; P Hobart; M Manthorpe; J A Norman; S E Parker
Journal:  Cancer Gene Ther       Date:  1998 Sep-Oct       Impact factor: 5.987

7.  Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects.

Authors:  Takeshi Kubota; Hitoshi Fujiwara; Hisashi Amaike; Kazuhiro Takashima; Satoshi Inada; Kiyoto Atsuji; Mamoru Yoshimura; Kunio Matsumoto; Toshikazu Nakamura; Hisakazu Yamagishi
Journal:  Cancer Sci       Date:  2004-04       Impact factor: 6.716

8.  Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.

Authors:  N Topf; S Worgall; N R Hackett; R G Crystal
Journal:  Gene Ther       Date:  1998-04       Impact factor: 5.250

9.  In vivo microscopy of hepatic metastases: dynamic observation of tumor cell invasion and interaction with Kupffer cells.

Authors:  Z Kan; K Ivancev; A Lunderquist; P A McCuskey; R S McCuskey; S Wallace
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

10.  Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.

Authors:  Ji Hee Lee; Young-Woo Seo; Sei Ryun Park; Young Jin Kim; Kyung Keun Kim
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  17 in total

1.  A novel animal model for in vivo study of liver cancer metastasis.

Authors:  Shinsuke Fujiwara; Hikaru Fujioka; Chise Tateno; Ken Taniguchi; Masahiro Ito; Hiroshi Ohishi; Rie Utoh; Hiromi Ishibashi; Takashi Kanematsu; Katsutoshi Yoshizato
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

2.  Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases.

Authors:  Martin Grimm; Martin Gasser; Marco Bueter; Johanna Strehl; Johann Wang; Ekaterina Nichiporuk; Detlef Meyer; Christoph T Germer; Ana M Waaga-Gasser; Andreas Thalheimer
Journal:  BMC Cancer       Date:  2010-03-07       Impact factor: 4.430

3.  Human liver umbilical fissure variants: pons hepatis (ligamentum teres tunnel).

Authors:  Shamir O Cawich; Michael T Gardner; Ramnanand Shetty; Neil W Pearce; Rahul Deshpande; Vijay Naraynsingh; Thomas Armstrong
Journal:  Surg Radiol Anat       Date:  2021-02-04       Impact factor: 1.246

4.  Preferential accumulation within tumors and in vivo imaging by functionalized luminescent dendrimer lanthanide complexes.

Authors:  Marco A Alcala; Chad M Shade; Hyounsoo Uh; Shu Ying Kwan; Matthias Bischof; Zachary P Thompson; Kristy A Gogick; Adam R Meier; Timothy G Strein; David L Bartlett; Ruth A Modzelewski; Yong J Lee; Stéphane Petoud; Charles K Brown
Journal:  Biomaterials       Date:  2011-09-16       Impact factor: 12.479

5.  Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells.

Authors:  Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 5.150

6.  Changes of T cells and cytokines TGF-β1 and IL-10 in mice during liver metastasis of colon carcinoma: implications for liver anti-tumor immunity.

Authors:  Xiaoming Huang; Yifeng Zou; Lei Lian; Xiaojian Wu; Xiaosheng He; Xiaowen He; Xianrui Wu; Yan Huang; Ping Lan
Journal:  J Gastrointest Surg       Date:  2013-05-14       Impact factor: 3.452

7.  Impact of surgical extent and sex on the hepatic metastasis of colon cancer.

Authors:  Liat Sorski; Ben Levi; Lee Shaashua; Elad Neeman; Marganit Benish; Pini Matzner; Aviad Hoffman; Shamgar Ben-Eliyahu
Journal:  Surg Today       Date:  2013-11-06       Impact factor: 2.549

8.  The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.

Authors:  Moritz J Strowitzki; Stefan Dold; Maximilian von Heesen; Christina Körbel; Claudia Scheuer; Mohammed R Moussavian; Martin K Schilling; Otto Kollmar; Michael D Menger
Journal:  Clin Exp Metastasis       Date:  2014-07-23       Impact factor: 5.150

9.  Modeling the behavior of uveal melanoma in the liver.

Authors:  Robert Folberg; Lu Leach; Klara Valyi-Nagy; Amy Y Lin; Marsha A Apushkin; Zhuming Ai; Vivian Barak; Dibyen Majumdar; Jacob Pe'er; Andrew J Maniotis
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

10.  Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis.

Authors:  Otto Kollmar; Kathrin Rupertus; Claudia Scheuer; Bastian Junker; Bettina Tilton; Martin K Schilling; Michael D Menger
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.